AI News NQ Analysis

NEC Group's blood testing service 'FonesVisuas' adopted by Royal Healthcare, a medical institution for high-net-worth individuals in Singapore

NQ Score 50/100

AI Summary (NQ-processed)

NEC's blood testing service adopted in Singapore.

AI analysis data is not yet available.

Frequently Asked Questions

Q: Which medical institution in Singapore has adopted the "FonesVisuas Test"?
A: Royal Healthcare, a Singapore-based medical institution and a subsidiary of Sojitz Corporation, has adopted it.
Q: What does the FonesVisuas service analyze to visualize the state of the body?
A: It analyzes proteins that change daily from a small amount of blood to visualize the body's state.
Q: Which diseases can the FonesVisuas service predict the risk of developing?
A: It predicts the risk of dementia, myocardial infarction, stroke, lung cancer, chronic kidney failure, and prostate cancer.
Q: Where is Royal Healthcare based and what type of services does it provide?
A: It is based in Novena, Singapore, and provides personalized, high-quality health checkup services.
Q: In which region does NEC intend to expand the sales of FonesVisuas overseas?
A: NEC intends to expand the sales of FonesVisuas overseas, with a focus on the APAC region.